aot2022v55i2

Acta Oncologica Turcica 2022
1
INSTRUCTION TO THE AUTHORS
The manuscripts regarding with hematological malignancies and oncology, written in
English will be accepted to the Acta Oncologica Turcica, which is the scientific journal of
Ankara Hematology Oncology Association.
The abbreviation of the Acta OncologicaTurcica is “Acta Oncol Tur.”.
Manuscripts that are not compatible with the journal format are sent back to the
corresponding author without reviewer assignment.
During submission, all manuscripts should be checked primarily for plagiarism rate and
grammatical rules. Except for the references section, the plagiarism rate should be below
20%. The author is responsible for obtaining the plagiarism report and the accuracy of the
report obtained.
The scientific and the legal responsibilities belong to the authors. The copyrights of the
publications belong to the Acta Oncologica Turcica. The authors are responsible for the
content of the papers and for the accuracy of the references.
The authors must submit 'Copyright Transfer Form' during the submission of manuscript. By
signing the 'Copyright Transfer Form' the authors guarantee the fact that the article has not
been published nor under consideration for publication in whole or in part, elsewhere. The
authors attest to the fact that they all have read the manuscript, attest to the validity and
legitimacy of the data and its interpretation, and agree to its submission to the Acta
Oncologica Turcica.
All research articles should be conducted in accordance with the Helsinki Declaration(revised
in 2013) and manuscripts should include a statement that the research protocol was
approved by the Institutional Ethical Committee or equivalent. Both the 'Informed
Consent' and approval from ethical committee should be described in the 'Materials and
Methods' section of the manuscript.
For peer-review process, a blind manuscript should be prepared by the author and submitted
to the system as a separate file.
For the experimental animal studies, the authors must include a statement that they protect the
animal rights according to the "Guide for the care and use of laboratory animals"
( http://oacu.od.nih.gov/regs/guide/guide.pdf) and must obtain approval from Institutional
Ethical Committee.
All sources of funds supporting the work and a statement of financial interest, if any, must be
included, along with a list of all products, devices, drugs, etc., used in the manuscript. Each
author must disclose at the time of submission any commercial associations or financial
disclosures that might pose or create a conflict of interest. Such associations include
consultancies, stock ownership, or other equity interests, and payments for conducting a study
described in the manuscript. Authors must disclose any funding received for the work from
any organizations within the cover letter to the editor. The statement of conflict of interest
www.actaoncologicaturcica.com
Copyright©Ankara Onkoloji Hastanesi